# Guilin Sanjin Pharmaceutical Co Ltd – FDA Inspection, May 19, 2017

Source: https://www.keypedia.com/records/fda_inspections/guilin-sanjin-pharmaceutical-co-ltd/2cc9af10-2d03-45a7-8fff-78322fe083d3
Source feed: FDA_Inspections

> FDA inspection 1014639 of Guilin Sanjin Pharmaceutical Co Ltd, May 19, 2017. Classification: Voluntary Action Indicated (VAI). Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1014639
- Company Name: Guilin Sanjin Pharmaceutical Co Ltd
- Inspection Date: 2017-05-19
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/alice-s-tsao/b6d72ceb-de7c-413d-b104-cac3b075c170)

Company: https://www.keypedia.com/companies/guilin-sanjin-pharmaceutical-co-ltd/8cb36cda-0219-4282-a88a-d111d7ba9350

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c